Form 10-Q
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2007

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

 


PRAXAIR, INC.

(Exact name of registrant as specified in its charter)

 


DELAWARE

(State or other jurisdiction of incorporation)

 

1-11037   06-1249050
(Commission File Number)   (IRS Employer Identification No.)

 

39 OLD RIDGEBURY ROAD, DANBURY, CT   06810-5113
(Address of principal executive offices)   (Zip Code)

(203) 837-2000

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

 


Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  x    Accelerated filer  ¨    Non-accelerated filer  ¨

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

At September 28, 2007, 315,910,966 shares of common stock ($0.01 par value) of the Registrant were outstanding.

 



Table of Contents

INDEX

 

     PAGE

PART I - FINANCIAL INFORMATION

  
Item 1.   Financial Statements   
  Consolidated Statements of Income - Praxair, Inc. and Subsidiaries Quarter Ended September 30, 2007 and 2006 (Unaudited)    3
  Consolidated Statements of Income - Praxair, Inc. and Subsidiaries Nine Months Ended September 30, 2007 and 2006 (Unaudited)    4
  Condensed Consolidated Balance Sheets - Praxair, Inc. and Subsidiaries September 30, 2007 and December 31, 2006 (Unaudited)    5
  Condensed Consolidated Statements of Cash Flows - Praxair, Inc. and Subsidiaries Nine Months Ended September 30, 2007 and 2006 (Unaudited)    6
  Consolidated Statement of Shareholders’ Equity - Praxair, Inc. and Subsidiaries Nine Months Ended September 30, 2007 (Unaudited)    7
  Notes to Condensed Consolidated Financial Statements - Praxair, Inc. and Subsidiaries (Unaudited)    8
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations    17
Item 3.   Quantitative and Qualitative Disclosures about Market Risk    24
Item 4.   Controls and Procedures    24
Item 4T.   Controls and Procedures    24

PART II – OTHER INFORMATION

  
Item 1.   Legal Proceedings    25
Item 1A.   Risk Factors    25
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds    25
Item 3.   Defaults Upon Senior Securities    25
Item 4.   Submission of Matters to a Vote of Security Holders    26
Item 5.   Other Information    26
Item 6.   Exhibits    26
Signature    27

 

2


Table of Contents

PART I – FINANCIAL INFORMATION

Praxair, Inc. and Subsidiaries


Item 1. Financial Statements

PRAXAIR, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Millions of dollars, except per share data)

(UNAUDITED)

 

     Quarter Ended
September 30,
 
   2007     2006  

SALES

   $ 2,372     $ 2,099  

Cost of sales, exclusive of depreciation and amortization

     1,394       1,259  

Selling, general and administrative

     294       272  

Depreciation and amortization

     196       173  

Research and development

     24       21  

Other income (expense) – net

     (4 )     18  
                

OPERATING PROFIT

     460       392  

Interest expense – net

     44       38  
                

INCOME BEFORE INCOME TAXES

     416       354  

Income taxes

     106       101  
                
     310       253  

Minority interests

     (9 )     (7 )

Income from equity investments

     4       1  
                

NET INCOME

   $ 305     $ 247  
                

PER SHARE DATA:

    

Basic earnings per share

   $ 0.96     $ 0.76  
                

Diluted earnings per share

   $ 0.94     $ 0.75  
                

Cash dividends per share

   $ 0.30     $ 0.25  
                

WEIGHTED AVERAGE SHARES OUTSTANDING (000’s):

    

Basic shares outstanding

     318,513       323,582  

Diluted shares outstanding

     324,920       329,498  

The accompanying notes are an integral part of these financial statements.

 

3


Table of Contents

PRAXAIR, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Millions of dollars, except per share data)

(UNAUDITED)

 

     Nine Months Ended
September 30,
 
   2007     2006  

SALES

   $ 6,879     $ 6,201  

Cost of sales, exclusive of depreciation and amortization

     4,064       3,704  

Selling, general and administrative

     876       816  

Depreciation and amortization

     567       518  

Research and development

     72       64  

Other income (expense) – net

     2       27  
                

OPERATING PROFIT

     1,302       1,126  

Interest expense – net

     123       117  
                

INCOME BEFORE INCOME TAXES

     1,179       1,009  

Income taxes

     304       274  
                
     875       735  

Minority interests

     (27 )     (22 )

Income from equity investments

     13       6  
                

NET INCOME

   $ 861     $ 719  
                

PER SHARE DATA:

    

Basic earnings per share

   $ 2.69     $ 2.22  
                

Diluted earnings per share

   $ 2.64     $ 2.18  
                

Cash dividends per share

   $ 0.90     $ 0.75  
                

WEIGHTED AVERAGE SHARES OUTSTANDING (000’s):

    

Basic shares outstanding

     319,830       323,635  

Diluted shares outstanding

     325,809       329,512  

The accompanying notes are an integral part of these financial statements.

 

4


Table of Contents

PRAXAIR, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Millions of dollars)

(UNAUDITED)

 

     September 30,
2007
   December 31,
2006

ASSETS

     

Cash and cash equivalents

   $ 26    $ 36

Accounts receivable – net

     1,707      1,456

Inventories

     448      381

Prepaid and other current assets

     227      186
             

TOTAL CURRENT ASSETS

     2,408      2,059

Property, plant and equipment (less accumulated depreciation of $7,983 at September 30, 2007 and $7,203 at December 31, 2006)

     7,598      6,694

Goodwill

     1,877      1,613

Other intangible assets – net

     116      71

Other long-term assets

     752      665
             

TOTAL ASSETS

   $ 12,751    $ 11,102
             

LIABILITIES AND EQUITY

     

Accounts payable

   $ 777    $ 682

Short-term debt

     617      130

Current portion of long-term debt

     44      56

Other current liabilities

     1,087      890
             

TOTAL CURRENT LIABILITIES

     2,525      1,758

Long-term debt

     3,342      2,981

Other long-term obligations

     1,767      1,587
             

TOTAL LIABILITIES

     7,634      6,326
             

Commitments and contingencies (Note 9)

     

Minority interests

     255      222

Shareholders’ equity

     4,862      4,554
             

TOTAL LIABILITIES AND EQUITY

   $ 12,751    $ 11,102
             

The accompanying notes are an integral part of these financial statements.

 

5


Table of Contents

PRAXAIR, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Millions of dollars)

(UNAUDITED)

 

     Nine Months Ended
September 30,
 
   2007     2006  

OPERATIONS

    

Net income

   $ 861     $ 719  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     567       518  

Deferred income taxes

     19       105  

Share-based compensation

     31       32  

Accounts receivable

     (222 )     (98 )

Inventory

     (55 )     (33 )

Prepaid and other current assets

     (16 )     (5 )

Payables and accruals

     133       109  

Pension contributions

     (16 )     (119 )

Other

     69       (39 )
                

Net cash provided by operating activities

     1,371       1,189  
                

INVESTING

    

Capital expenditures

     (974 )     (800 )

Acquisitions

     (349 )     (7 )

Divestitures and asset sales

     33       112  
                

Net cash used for investing activities

     (1,290 )     (695 )
                

FINANCING

    

Short-term debt borrowings (repayments) – net

     441       (161 )

Long-term debt borrowings

     575       78  

Long-term debt repayments

     (296 )     (263 )

Issuances of common stock

     245       203  

Purchases of common stock

     (816 )     (262 )

Cash dividends

     (287 )     (242 )

Excess tax benefit on stock option exercises

     54       18  

Minority interest transactions and other

     (12 )     (18 )
                

Net cash used for financing activities

     (96 )     (647 )
                

Effect of exchange rate changes on cash and cash equivalents

     5       2  
                

Change in cash and cash equivalents

     (10 )     (151 )

Cash and cash equivalents, beginning-of-period

     36       173  
                

Cash and cash equivalents, end-of-period

   $ 26     $ 22  
                

The accompanying notes are an integral part of these financial statements.

 

6


Table of Contents

PRAXAIR, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY

(Dollar amounts in millions, except share data, shares in thousands)

(UNAUDITED)

 

Activity

   Common Stock    Additional
Paid-In
Capital
   Treasury Stock     Retained
Earnings
    Accumulated
Other
Comprehensive
Income (Loss)(b)
    Total  
   Shares    Amounts       Shares     Amounts        

Balance, January 1, 2007

   367,645    $ 4    $ 2,729    46,784     $ (1,739 )   $ 4,687     $ (1,127 )   $ 4,554  

Net income

                  861         861  

Translation adjustments

                    331       331  

SFAS No. 158 pension liability, net of $11 million of taxes

                    18       18  
                         

Comprehensive income(a)

                      1,210  
                         

FIN 48 (Note 11)

                  (158 )       (158 )

Dividends on common stock ($0.90 per share)

                  (287 )       (287 )

Issuances of common stock:

                   

For the dividend reinvestment and stock purchase plan

   65         5              5  

For employee savings and incentive plans

   4,915         182    (1,690 )     68           250  

Purchases of common stock

            11,620       (810 )         (810 )

Tax benefit from stock options

           67              67  

Share-based compensation

           31              31  
                                                         

Balance, September 30, 2007

   372,625    $ 4    $ 3,014    56,714     $ (2,481 )   $ 5,103     $ (778 )   $ 4,862  
                                                         

(a)

The components of comprehensive income are as follows:

 

     Quarter Ended September 30,    Nine Months Ended September 30,  
   2007    2006    2007    2006  

Net income

   $ 305    $ 247    $ 861    $ 719  

Translation adjustments

     123      36      331      130  

Pension/OPEB funded status obligation *

     11      —        18      (11 )
                             
   $ 439    $ 283    $ 1,210    $ 838  
                             

* Minimum pension liability in 2006.

 

(b)

The components of accumulated other comprehensive income (loss) are as follows:

 

    

September 30,

2007

    

December 31,

2006

 

Accumulated translation adjustments

   $ (544 )    $ (875 )

Accumulated pension/OPEB funded status obligation

     (233 )      (251 )

Accumulated derivatives

     (1 )      (1 )
                 
   $ (778 )    $ (1,127 )
                 

The accompanying notes are an integral part of these financial statements.

 

7


Table of Contents

PRAXAIR, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. Summary of Significant Accounting Policies

Presentation of Condensed Consolidated Financial StatementsIn the opinion of Praxair, Inc. (Praxair) management, the accompanying condensed consolidated financial statements include all adjustments necessary for a fair presentation of the results for the interim periods presented and such adjustments are of a normal recurring nature. The accompanying condensed consolidated financial statements should be read in conjunction with the Notes to the consolidated financial statements of Praxair, Inc. and subsidiaries in Praxair’s 2006 Annual Report. There have been no material changes to the company’s significant accounting policies during 2007 except for the adoption of FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement 109” (FIN 48), effective January 1, 2007.

Accounting Standards Implemented in 2007

Effective January 1, 2007, Praxair adopted FIN 48 which clarifies the accounting for uncertainty in income taxes recognized in accordance with FASB Statement No. 109, “Accounting for Income Taxes” (SFAS 109). See Note 11 for information relating to the implementation of this interpretation and other required disclosures pertaining to uncertain tax positions.

Accounting Standards to Be Implemented

In September 2006, the FASB issued Statement of Financial Accounting Standard No. 157, “Fair Value Measurements,” which provides a single definition of fair value, and requires additional disclosure about the use of fair value to measure assets and liabilities. The standard emphasizes that fair value is a market-based measurement and should be determined based on the assumptions that market participants would use in valuing assets or liabilities. This standard is effective on January 1, 2008 for Praxair and the company is currently in the process of evaluating the impact of this interpretation on the consolidated financial statements.

In February 2007, the FASB issued Statement of Financial Accounting Standard No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities – Including an amendment of FASB Statement No. 115”. This statement permits companies, at their option, to choose to measure many financial instruments and certain other items at fair value. If the option to use fair value is chosen, the standard requires additional disclosures related to the fair value measurements included in the financial statements. This statement is effective on January 1, 2008 for Praxair and the company does not anticipate that this statement will have a significant impact on the consolidated financial statements.

2. Share-Based Compensation

The company accounts for share-based compensation under the provisions of Statement of Financial Accounting Standard No. 123 (revised 2004), “Share-Based Payment” (SFAS No. 123R). Share-based compensation of $10 million ($8 million after tax) and $10 million ($7 million after tax) was recognized during the quarters ended September 30, 2007 and 2006, respectively. Share-based compensation of $31 million ($23 million after tax) and $32 million ($21 million after tax) was recognized for the nine months ended September 30, 2007 and 2006, respectively. The expense was primarily recorded in selling, general and administrative expenses. There was no share-based compensation cost capitalized. For further details regarding Praxair’s share-based compensation arrangements, refer to Note 16 to the consolidated financial statements included on page 57 of Praxair’s 2006 Annual Report.

Stock Options

There were 5,000 and 3,816,350 options granted during the quarter and nine months ended September 30, 2007, respectively. The weighted-average fair value of options granted during the quarter and nine months ended September 30, 2007 was $13.15 and $10.97, respectively, based on the Black-Scholes Options-Pricing model. The weighted-average fair value of options granted during the quarter and nine months ended September 30, 2006 was $11.61 and $10.85, respectively, based on the Black-Scholes Options-Pricing model. The following weighted-average assumptions were used for grants in 2007 and 2006:

 

8


Table of Contents
     Quarter Ended
September 30,
    Nine Months Ended
September 30,
 
   2007     2006     2007     2006  

Dividend yield

   1.59 %   1.82 %   1.95 %   1.85 %

Volatility

   13.65 %   17.20 %   15.32 %   17.64 %

Risk-free interest rate

   4.31 %   5.20 %   4.52 %   4.65 %

Expected term years

   5     5     5     5  

The following table summarizes option activity under the plans as of September 30, 2007 and changes during the nine-month period then ended (averages are calculated on a weighted basis; life in years; intrinsic value expressed in millions):

 

Activity

   Number of
Options (000’s)
    Average
Exercise Price
   Average
Remaining
Life
   Aggregate
Intrinsic
Value

Outstanding at January 1, 2007

   21,771     $ 35.28      

Granted

   3,816       61.49      

Exercised

   (5,230 )     29.44      

Cancelled or expired

   (273 )     46.19      
              

Outstanding at September 30, 2007

   20,084       41.54    6.6    $ 848
                        

Exercisable at September 30, 2007

   12,478     $ 32.75    5.3    $ 637
                        

The aggregate intrinsic value represents the difference between the company’s closing stock price of $83.76 as of September 28, 2007 and the exercise price multiplied by the number of options outstanding as of that date. The total intrinsic value of stock options exercised during the quarter and nine months ended September 30, 2007 was $75 million and $211 million, respectively ($29 million and $82 million for the same time periods in 2006, respectively).

Cash received from option exercises under all share-based payment arrangements for the quarter and nine months ended September 30, 2007 was $50 million and $154 million, respectively ($24 million and $72 million for the same time periods in 2006, respectively). The actual tax benefit realized from stock option exercises totaled $24 million and $67 million for the quarter and nine months ended September 30, 2007, respectively ($8 million and $25 million for the same time periods in 2006, respectively).

As of September 30, 2007, $48 million of unrecognized compensation cost related to non-vested stock options is expected to be recognized over a weighted-average period of approximately 1.5 years.

Performance-Based and Restricted Stock Awards

During February 2007, the company granted performance based stock awards to senior level executives for 70,520 shares that vest based on the attainment of specified performance targets over a two-year performance period from January 1, 2007 to December 31, 2008. At the end of the performance period, the actual number of shares issued can range from zero to 200 percent of the shares granted. Compensation expense related to these awards is recognized over the two-year performance period based on the fair value of the closing market price of the Company’s common stock on the date of the grant ($61.47 per share) and the estimated performance that will be achieved. In addition, the company has granted restricted stock to certain key employees that vest after a designated service period ranging from two to ten years.

The following table summarizes nonvested performance-based and restricted stock award activity as of September 30, 2007 and changes during the period then ended (averages are calculated on a weighted basis):

 

9


Table of Contents

Performance-Based and Restricted Stock Activity

   Number of
Shares (000’s)
    Average Grant
Date Fair Value

Nonvested at January 1, 2007

   63     $ 21.35

Granted

   71       61.47

Vested

   (27 )     21.01

Forfeited

   (17 )     19.72
        

Nonvested at September 30, 2007

   90    
        

As of September 30, 2007, $4 million of unrecognized compensation cost related to performance-based awards is expected to be recognized on a straight-line basis through 2009 and less than $1 million of unrecognized compensation cost related to the restricted stock awards is expected to be recognized on a straight-line basis through 2011.

3. Inventories

The following is a summary of Praxair’s consolidated inventories:

 

(Millions of dollars)

   September 30,
2007
   December 31,
2006

Raw materials and supplies

   $ 122    $ 104

Work in process

     64      50

Finished goods

     262      227
             
   $ 448    $ 381
             

 

10


Table of Contents

4. Debt

The following is a summary of Praxair’s outstanding debt at September 30, 2007 and December 31, 2006:

 

(Millions of dollars)

   September 30,
2007
    December 31,
2006
 

SHORT-TERM

    

Commercial paper and US bank borrowings

   $ 114     $ 9  

European borrowings

     16       —    

Canadian borrowings

     265       —    

South American borrowings

     34       35  

Asian borrowings

     171       79  

Other international borrowings

     17       7  
                

Total short-term debt

     617       130  
                

LONG-TERM

    

U.S. borrowings

    

Commercial paper (c)

     250       —    

4.75% Notes due 2007 (d)

     —         250  

6.625% Notes due 2007 (c, d)

     250       250  

6.50% Notes due 2008 (c)

     250       250  

2.75% Notes due 2008 (a, c)

     300       299  

6.375% Notes due 2012 (a, b)

     522       524  

3.95% Notes due 2013 (a)

     349       349  

5.375% Notes due 2016 (a)

     399       399  

5.20% Notes due 2017 (a, e)

     324       —    

Other

     6       8  

European borrowings

     635       590  

South American borrowings

     76       83  

Asian borrowings

     11       21  

Other international borrowings

     5       4  

Obligations under capital leases

     9       10  
                
     3,386       3,037  

Less: current portion of long-term debt

     (44 )     (56 )
                

Total long-term debt

     3,342       2,981  
                

Total debt

   $ 4,003     $ 3,167  
                

(a)

Amounts are net of unamortized discounts.

(b)

September 30, 2007 and December 31, 2006 include a $23 million and $25 million fair value increase, respectively, related to SFAS 133 hedge accounting. See Note 13 on page 55 of the 2006 Annual Report.

(c)

Classified as long-term because of the Company’s intent to refinance this debt on a long-term basis and the availability of such financing under the terms of existing agreements.

(d)

On July 16, 2007 and October 15, 2007, Praxair repaid $250 million of 4.75% Notes and $250 million of 6.625% Notes, respectively, that were due. The repayments were initially funded through the issuance of commercial paper.

(e)

On March 15, 2007, Praxair issued $325 million of 5.20% Notes due 2017. The proceeds were used to refinance existing debt and for general corporate purposes.

 

11


Table of Contents

5. Financial Instruments

The following table is a summary of the notional amount of currency derivatives outstanding at September 30, 2007 and December 31, 2006 (all maturities within one year):

 

(Millions of dollars)

   September 30,
2007
   December 31,
2006

CURRENCY CONTRACTS

     

Balance sheet items

   $ 631    $ 758

Anticipated net income

     200      —  
             
   $ 831    $ 758
             

Praxair enters into currency exchange forward contracts and options to manage its exposure to fluctuations in foreign currency exchange rates. Hedges of balance-sheet items are related to recorded balance-sheet exposures, including intercompany transactions. The net income hedges outstanding at September 30, 2007 are related to anticipated net income in Brazil, Canada and Europe. There were no net income hedges outstanding at December 31, 2006. Other income (expense) – net includes an $8 million loss and a $9 million loss for the quarter and for the nine months ended September 30, 2007, respectively, related to net income hedges (no gain or loss for the quarter and nine months ended September 30, 2006).

At September 30, 2007, the fair value of all derivative instruments has been recorded in the condensed consolidated balance sheet as follows: $4 million in current assets and $15 million in current liabilities ($3 million in current assets and $3 million in current liabilities at December 31, 2006). There were no interest-rate derivatives outstanding at September 30, 2007 or December 31, 2006.

6. Earnings Per Share

Basic earnings per share is computed by dividing net income for the period by the weighted average number of Praxair common shares outstanding. Diluted earnings per share is computed by dividing net income for the period by the weighted average number of Praxair common shares outstanding and dilutive common stock equivalents, as follows:

 

     Quarter Ended
September 30,
   Nine Months Ended
September 30,
   2007    2006    2007    2006

NUMERATOR (MILLIONS OF DOLLARS)

           

Net income used in basic and diluted EPS

   $ 305    $ 247    $ 861    $ 719

DENOMINATOR (THOUSANDS OF SHARES)

           

Weighted average shares outstanding

     317,513      322,524      318,823      322,588

Shares earned and issuable under compensation plans

     1,000      1,058      1,007      1,047
                           

Weighted average shares used in basic earnings per share

     318,513      323,582      319,830      323,635

Effect of dilutive securities

           

Performance-based stock awards

     106      —        73      —  

Employee stock options

     6,301      5,916      5,906      5,877
                           

Weighted average shares used in diluted earnings per share

     324,920      329,498      325,809      329,512
                           

BASIC EARNINGS PER COMMON SHARE

   $ 0.96    $ 0.76    $ 2.69    $ 2.22

DILUTED EARNINGS PER COMMON SHARE

   $ 0.94    $ 0.75    $ 2.64    $ 2.18

 

12


Table of Contents

For the quarter and nine months ended September 30, 2007, no stock options and stock options for 5,000 shares, respectively, were excluded in the computation of diluted earnings per share because the exercise prices were greater than the average market price of the common stock. Stock options for 1,000 shares and 36,100 shares for the quarter and nine months ended September 30, 2006, respectively, were excluded in the computation of diluted earnings per share because the exercise prices were greater than the average market price of the common stock.

7. Goodwill and Other Intangible Assets

SFAS No. 142, “Goodwill and Other Intangible Assets,” requires the company to perform an assessment at least annually as to whether there is an indication that the carrying value of goodwill is impaired at the reporting unit level. The annual impairment tests for 2007 and 2006 were performed during the second quarter of each year and no impairments were indicated.

Changes in the carrying amount of goodwill for the nine months ended September 30, 2007 were as follows:

 

(Millions of dollars)

   North
America
    South
America
   Europe    Asia    Surface
Technologies
   Total

Balance, December 31, 2006

   $ 998     $ 181    $ 326    $ 29    $ 79    $ 1,613

Acquisitions (Note 12)

     178       1      —        —        —        179

Purchase adjustments

     (1 )     —        2      —        —        1

Foreign currency translation

     20       33      25      2      4      84
                                          

Balance, September 30, 2007

   $ 1,195     $ 215    $ 353    $ 31    $ 83    $ 1,877
                                          

Changes in the carrying amount of other intangibles for the nine months ended September 30, 2007 were as follows:

 

     Customer &
License/Use
Agreements
    Non-compete
Agreements
    Patents &
Other
    Total  

Cost:

        

Balance, December 31, 2006

   $ 72     $ 39     $ 16     $ 127  

Acquisitions (Note 12)

     51       6       —         57  

Foreign currency translation

     3       1       —         4  

Other

     —         (4 )     2       (2 )
                                

Balance, September 30, 2007

   $ 126     $ 42     $ 18     $ 186  
                                

Less: Accumulated amortization

        

Balance, December 31, 2006

   $ (26 )   $ (24 )   $ (6 )   $ (56 )

Amortization expense

     (7 )     (6 )     (1 )     (14 )

Foreign currency translation

     (1 )     (1 )     —         (2 )

Other

     —         4       (2 )     2  
                                

Balance, September 30, 2007

   $ (34 )   $ (27 )   $ (9 )   $ (70 )
                                

Net balance at September 30, 2007

   $ 92     $ 15     $ 9     $ 116  
                                

There are no expected residual values related to these intangible assets. The remaining weighted-average amortization period for intangible assets is approximately 11 years. Total estimated annual amortization expense is $6 million for the remainder of 2007; $16 million, $14 million, $13 million and $10 million for the years ended December 31, 2008, 2009, 2010 and 2011, respectively; and $57 million thereafter.

 

13


Table of Contents

8. Pension and OPEB

The components of net pension and postretirement benefits other than pensions (OPEB) costs for the quarters and nine-month periods ended September 30, 2007 and 2006 are shown below:

 

(Millions of dollars)

   Quarter Ended September 30,    Nine Months Ended September 30,
   Pensions     OPEB    Pensions     OPEB
   2007     2006     2007    2006    2007     2006     2007    2006

Service cost

   $ 11     $ 11     $ 1    $ 1    $ 33     $ 32     $ 3    $ 5

Interest cost

     27       24       4      4      81       72       12      12

Expected return on plan assets

     (32 )     (29 )     —        —        (95 )     (86 )     —        —  

Net amortization and deferral

     7       7       —        —        20       21       —        —  
                                                           

Net periodic benefit cost

   $ 13     $ 13     $ 5    $ 5    $ 39     $ 39     $ 15    $ 17
                                                           

Praxair estimates that 2007 contributions to its pension plans will be in the area of $25 million, of which $16 million have been made through September 30, 2007.

9. Commitments and Contingencies

Praxair is subject to various lawsuits and government investigations that arise from time to time within its global businesses. These actions are or may be based upon alleged environmental, tax, antitrust and personal injury claims, among others, and involve or may involve civil and criminal allegations. Praxair believes that it has strong defenses in the pending cases and investigations and intends to defend itself vigorously. It is possible that the Company may incur losses in connection with some of these actions in excess of accrued liabilities. Management does not anticipate that in the aggregate such losses would have a material adverse effect on the company’s consolidated financial position or liquidity; however, it is possible that the final outcomes could have a significant impact on the Company’s reported results of operations in any given period.

Among such matters are claims brought by welders alleging that exposure to manganese contained in welding fumes caused neurological injury. Praxair has never manufactured welding consumables. Such products were manufactured prior to 1985 by a predecessor company of Praxair. As of September 30, 2007, Praxair was a co-defendant with many other companies in 501 lawsuits alleging personal injury caused by manganese contained in welding fumes. There were a total of 3,057 individual claimants in these cases. The cases were pending in several state and federal courts. The federal cases have been transferred to the U.S. District Court for the Northern District of Ohio for coordinated pretrial proceedings. The plaintiffs seek unspecified compensatory and, in most instances, punitive damages. In the past, Praxair has either been dismissed from the cases with no payment or has settled a few cases for nominal amounts. There are seven proposed class actions seeking medical monitoring on behalf of welders. None of the class actions have been certified; the judge overseeing the federal cases recently denied a motion for a medical monitoring class action. No reserves have been recorded for these cases as management does not believe that a loss from them is probable or reasonably estimable.

At September 30, 2007, Praxair had undrawn outstanding letters of credit, bank guarantees and surety bonds valued at approximately $869 million from financial institutions. These related primarily to customer contract performance guarantees (including plant construction in connection with certain on-site contracts), self-insurance claims and other commercial and governmental requirements and proceedings. See Note 18 on page 62 of the 2006 Annual Report for more information concerning commitments and contingencies.

 

14


Table of Contents

10. Segments

Sales and operating profit by segment for the quarters and nine-month periods ended September 30, 2007 and 2006 are shown below (for a description of Praxair’s operating segments, refer to Note 19 to the consolidated financial statements included on page 63 of Praxair’s 2006 Annual Report):

 

(Dollar amounts in millions)

   Quarter Ended
September 30,
   Nine Months Ended
September 30,
   2007    2006    2007    2006

SALES(a)

           

North America

   $ 1,306    $ 1,187    $ 3,804    $ 3,514

Europe

     325      293      991      857

South America

     419      340      1,160      997

Asia

     190      165      536      467

Surface Technologies

     132      114      388      366
                           
   $ 2,372    $ 2,099    $ 6,879    $ 6,201
                           

OPERATING PROFIT

           

North America

   $ 244    $ 204    $ 692    $ 619

Europe

     78      69      229      193

South America

     84      69      226      184

Asia

     30      27      87      78

Surface Technologies

     24      23      68      52
                           
   $ 460    $ 392    $ 1,302    $ 1,126
                           

(a)

Intersegment sales, primarily from North America to other segments, were not significant for the quarters and nine-month periods ended September 30, 2007 and 2006.

11. Income Taxes

Effective January 1, 2007, Praxair adopted FIN 48 which provides a comprehensive model for the recognition, measurement and disclosure in financial statements of uncertain income tax positions that a company has taken or expects to take on a tax return. Under FIN 48, a company can recognize the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit can be recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. Additionally, companies are required to accrue interest and related penalties, if applicable, on all tax exposures for which reserves have been established consistent with jurisdictional tax laws. The adoption of FIN 48 resulted in a non-cash transition charge of $158 million, recorded as a reduction to beginning retained earnings. The transition adjustment relates primarily to tax positions related to foreign operations where the original tax benefit related to periods prior to 2002. Interest and penalties on tax reserves are classified as income tax expense in the financial statements.

As of January 1, 2007, the Company has unrecognized income tax benefits totaling $309 million and related accrued interest and penalties of $31 million (after related tax benefits), which were primarily recorded in Other long-term obligations in the condensed consolidated balance sheet. If recognized, essentially all of the unrecognized tax benefits and related interest and penalties would be recorded as a benefit to income tax expense on the consolidated statement of income. During the three months ended September 30, 2007, unrecognized tax benefits and related interest and penalties were reduced by approximately $69 million for tax settlements. Such tax settlements were fully accrued and are reflected in Other current liabilities at September 30, 2007. Also, management currently believes that it is reasonably possible that up to an additional $50 million of unrecognized tax benefits and related interest and penalties may be reduced by tax settlements over the next year. Such amounts are fully accrued at September 30, 2007 and, if settled, would not result in any significant gain or loss.

 

15


Table of Contents

As of January 1, 2007, the company remained subject to examination in the following major tax jurisdictions for the tax years as indicated below:

 

Major Tax Jurisdictions

  

Open Years

North America   

United States

   2005 and 2006

Canada

   1999 through 2006

Mexico

   2002 through 2006
Europe   

Germany

   2004 through 2006

Italy

   2002 through 2006

Spain

   1997 through 2006
South America   

Brazil

   1998 through 2006
Asia   

China

   2006

India

   1999 through 2006

Korea

   2002 through 2006

Thailand

   2002 through 2006

On October 1, 2007, Mexico enacted a new tax law, effective in 2008, which replaces the current asset tax with a new flat tax as a supplement to the regular income tax. The Company is evaluating the effects of this change in tax law and will make appropriate adjustments, if any, in the fourth quarter.

12. Acquisitions

During the nine months ended September 30, 2007, Praxair acquired Linde AG’s industrial and medical gas business in Mexico and Mittler Supply, Inc., an independent packaged gas distributor with operations across the midwestern United States. In addition, Praxair completed several small acquisitions, primarily North American packaged gas distributors. The aggregate purchase price for acquisitions was $349 million and resulted in the recognition of $179 million of goodwill.

The results of operations of these businesses have been included in Praxair’s consolidated statements of income since their respective dates of acquisition. The allocations of the purchase price are based on preliminary estimates and assumptions at the date of acquisition and are subject to revision based on final information received, including appraisals and other analyses that support underlying estimates.

 

16


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Consolidated Results

The following table provides summary data for the quarters and nine-month periods ended September 30, 2007 and 2006:

 

(Dollar amounts in millions)

   Quarter Ended September 30,     Nine Months Ended September 30,  
   2007     2006     Variance     2007     2006     Variance  

Sales

   $ 2,372     $ 2,099     +13 %   $ 6,879     $ 6,201     +11 %

Gross margin(a)

   $ 978     $ 840     +16 %   $ 2,815     $ 2,497     +13 %

As a percent of sales

     41.2 %     40.0 %       40.9 %     40.3 %  

Selling, general and administrative

   $ 294     $ 272     +8 %   $ 876     $ 816     +7 %

As a percent of sales

     12.4 %     13.0 %       12.7 %     13.2 %  

Depreciation and amortization

   $ 196     $ 173     +13 %   $ 567     $ 518     +9 %

Other income (expenses) – net

   $ (4 )   $ 18       $ 2     $ 27    

Operating profit

   $ 460     $ 392     +17 %   $ 1,302     $ 1,126     +16 %

Interest expense – net

   $ 44     $ 38     +16 %   $ 123     $ 117     +5 %

Effective tax rate

     25.5 %     28.5 %       25.8 %     27.2 %  

Net income

   $ 305     $ 247     +23 %   $ 861     $ 719     +20 %

(a)

Gross margin excludes depreciation and amortization expense.

Sales increased $273 million, or 13%, for the third quarter and $678 million, or 11%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Sales grew in all geographies, led by growth in Asia and South America from new business and project start-ups, and continued volume growth in North America. Volume growth of 3% and 4% for the quarter and nine-month periods, respectively, reflects continued strong volumes to the manufacturing, energy, and metals end-markets. Higher pricing contributed 4% and 3% to sales growth for the quarter and nine-month periods, respectively. Currency appreciation, primarily in Europe and South America, increased sales by 4% and 3% for the quarter and nine-month periods, respectively. Acquisitions and divestitures contributed 2% and 1% to sales in the quarter and nine-month periods. The pass-through of natural gas costs to on-site hydrogen customers was neutral for the quarter and nine-month periods with minimal impact on operating profit.

Gross margin in 2007 improved $138 million, or 16%, for the third quarter and $318 million, or 13%, for the nine months ended September 30, 2007 versus the respective 2006 periods. The increases in the third quarter and nine-month gross margin percentages, to 41.2% and 40.9%, respectively, were due primarily to higher pricing and cost efficiency and productivity programs which outpaced underlying inflationary cost pressures.

Selling, general and administrative (SG&A) expenses for the third quarter were $294 million, or 12.4% of sales, versus $272 million, or 13.0% of sales, for the respective 2006 period. SG&A expenses for the nine-month period were $876 million, or 12.7% of sales, versus $816 million, or 13.2% of sales, for the respective 2006 period. The decrease in SG&A as a percentage of sales was due to realized benefits from productivity initiatives.

Depreciation and amortization expense increased $23 million, or 13%, for the third quarter and $49 million, or 9%, for the nine months ended September 30, 2007 versus the respective 2006 periods. The increase was principally due to new plant start-ups and currency effects.

Other income (expenses) – net was a $4 million expense and $2 million benefit for the quarter and nine months ended September 30, 2007, respectively, versus an $18 million and $27 million benefit for the respective 2006 periods. The 2007 quarter and nine-month periods included an $8 million and $9 million loss, respectively, related to net income hedges (see Note 5). The quarter ended September 30, 2006 included a $14 million gain related to two divestitures, the aviation services business and a Turkish joint venture. The 2006 nine-month period included the impact of the two divestitures and a $15 million gain resulting from insurance recoveries.

Operating profit increased $68 million, or 17%, for the third quarter and $176 million, or 16%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Excluding the impact of the two divestitures in the 2006 third quarter, underlying operating profit increased $82 million, or 22%, for the 2007 third quarter. This underlying increase was principally driven by new business, higher pricing, and the continued impact of focused productivity initiatives. The 2006 nine-month period included the impact of the two aforementioned divestitures and a $15 million benefit from insurance recoveries.

 

17


Table of Contents

Interest expense – net increased $6 million, or 16% for the third quarter and increased $6 million, or 5%, for the nine-month period ended September 30, 2007 versus 2006 as a result of higher debt balances used for capital expenditures, acquisitions and share repurchases. The increase in interest expense was partially offset by the capitalization of interest related to higher capital expenditures on the company’s backlog of capital expenditures.

The effective tax rate was 25.5% for the third quarter and 25.8% for the nine-month period versus 28.5% and 27.2%, respectively, for the same periods in 2006. The 2007 quarter and nine-month periods include a $2 million net benefit due to the third quarter income tax rate reduction in Germany which was partially offset by prior year adjustments related to international operations. The 2006 quarter and year to date periods include $11 million of income tax charges related to the divestiture of its aviation services business and a Turkish joint venture. Excluding these tax items, the underlying effective tax rates for the quarter and nine-month periods were approximately 26% in 2007 and 26.5% in 2006.

Net income increased $58 million, or 23%, for the third quarter and $142 million, or 20%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Operating profit growth was the primary driver of the net income improvement.

The number of employees at September 30, 2007 was 27,479, an increase of 437 employees from December 31, 2006, primarily due to acquisitions completed in 2007.

Segment Discussion

The following summary of sales and operating profit by segment provides a basis for the discussion that follows:

 

(Dollar amounts in millions)

   Quarter Ended September 30,     Nine Months Ended September 30,  
   2007    2006    Variance     2007    2006    Variance  

SALES

                

North America

   $ 1,306    $ 1,187    +10 %   $ 3,804    $ 3,514    +8 %

Europe

     325      293    +11 %     991      857    +16 %

South America

     419      340    +23 %     1,160      997    +16 %

Asia

     190      165    +15 %     536      467    +15 %

Surface Technologies

     132      114    +16 %     388      366    +6 %
                                
   $ 2,372    $ 2,099    +13 %   $ 6,879    $ 6,201    +11 %
                                

OPERATING PROFIT

                

North America

   $ 244    $ 204    +20 %   $ 692    $ 619    +12 %

Europe

     78      69    +13 %     229      193    +19 %

South America

     84      69    +22 %     226      184    +23 %

Asia

     30      27    +11 %     87      78    +12 %

Surface Technologies

     24      23    +4 %     68      52    +31 %
                                
   $ 460    $ 392    +17 %   $ 1,302    $ 1,126    +16 %
                                

North America

Sales increased $119 million, or 10%, for the third quarter and $290 million, or 8%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Higher pricing increased sales by 4% for the quarter and nine-month periods due to pricing actions to recover higher costs. Volume growth was 2% for the quarter and nine-month periods from higher on-site, merchant liquid and packaged gases volumes primarily to the energy and general manufacturing end-markets. Currency appreciation in Canada contributed 1% to sales in the quarter and was neutral to sales in the nine-month period. Acquisitions contributed 4% and 2% to sales in the quarter and nine-month periods. The pass-through of natural gas costs to on-site hydrogen customers decreased sales by 1% for the quarter and was neutral to sales in the nine-month period with minimal impact on operating profit.

 

18


Table of Contents

Operating profit increased $40 million, or 20%, for the third quarter and $73 million, or 12%, for the nine months ended September 30, 2007 versus the respective 2006 periods. The nine-month period ended September 30, 2006 included a $15 million benefit from insurance recoveries. Excluding the insurance recoveries in 2006, operating profit increased $88 million, or 15%, for the nine months ended September 30, 2007. Volume growth, realized price increases and the continued impact of cost-reduction programs were the primary drivers to the strong operating profit growth in the quarter and nine-month periods.

During the nine months ended September 30, 2007, Praxair acquired Linde AG’s industrial and medical gas business in Mexico as well as Mittler Supply, Inc., an independent packaged gas distributor with operations across the midwestern United States. In addition, Praxair completed the acquisition of several smaller packaged gas distributors in North America (see Note 12 to the condensed consolidated financial statements).

Europe

Sales increased $32 million, or 11%, for the third quarter and $134 million, or 16%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Currency appreciation contributed 7% and 8% to sales growth in the quarter and nine-month periods, respectively. Volume growth of 2% and 5% in the quarter and nine-month periods, respectively, was due to strong packaged gas sales, new business applications and strong homecare sales in Spain. Realized price increases of 2% and 3% in the quarter and nine-month periods, respectively, included the pass through of higher energy and power costs.

Operating profit increased $9 million, or 13%, for the third quarter and $36 million, or 19%, for the nine months ended September 30, 2007 versus the respective 2006 periods. The quarter and nine months ended September 30, 2006 included a gain of $5 million from the divestiture of a Turkish joint venture. Excluding the impact of the divestiture from the 2006 periods, underlying operating profit increased $14 million, or 22%, for the quarter and $41 million, or 22%, for the nine-month period. Operating profit growth was driven by increased sales volumes, the continued impact of cost-reduction programs and currency appreciation.

On August 13, 2007, Praxair reached an agreement to sell its majority interest in Maxima Air Separation Center Ltd. with operations in Israel. In 2006, this business had sales of $23 million. Praxair anticipates the sale to close by the end of the fourth quarter of 2007.

South America

Sales increased $79 million, or 23%, for the third quarter and $163 million, or 16%, for the nine months ended September 30, 2007 versus the respective 2006 periods. The quarter and nine-month periods ended September 30, 2006 included an equipment sale to a Venezuela customer. Excluding the equipment sale in 2006 and currency appreciation, sales increased 15% and 12% for the quarter and nine-month periods, respectively, primarily due to strong growth in the manufacturing and metals end-markets and realized price increases.

Operating profit increased $15 million, or 22%, for the third quarter and $42 million, or 23%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Increased volumes, the continued impact of cost-reduction programs and higher pricing continued to outpace inflationary pressures, favorably contributing to operating profit growth. Currency appreciation also contributed to operating profit growth.

Asia

Sales increased $25 million, or 15%, for the third quarter and $69 million, or 15%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Excluding the impact of currency appreciation, sales increased 9% and 10% for the quarter and nine-month periods, respectively, due to strong on-site volumes in China, India and Korea primarily to the electronics end-market.

Operating profit increased $3 million, or 11%, for the third quarter and $9 million, or 12%, for the nine months ended September 30, 2007 versus the respective 2006 periods. Increased sales volumes and productivity initiatives were the primary drivers of operating profit growth offset by the impact of several temporary on-site customer outages during the quarter as well as the limited pass through of higher power costs due to merchant pricing pressures.

 

19


Table of Contents

Surface Technologies

Sales increased $18 million, or 16%, for the third quarter and $22 million, or 6%, for the nine months ended September 30, 2007 versus the respective 2006 periods. For the nine-month period, sales increased 15%, excluding the impact of the divestiture of its aviation services business in July 2006. The sales growth in the quarter and year-to-date period was primarily due to higher volumes of industrial coatings for power turbines and OEM aircraft engine parts and realized price increases. Currency appreciation, primarily in Europe, contributed 4% to sales growth in the quarter and nine-month periods.

Operating profit increased $1 million, or 4%, for the third quarter and $16 million, or 31%, for the nine-months ended September 30, 2007 versus the respective 2006 periods. The quarter and nine months ended September 30, 2006 included a gain of $7 million from the aviation services divestiture. Excluding this, underlying operating profit increased $8 million, or 50%, for the quarter and $23 million, or 51%, for the nine-month period. The increase was principally driven by volume growth as well as the favorable benefits of ongoing cost-reduction actions and pricing actions to offset increasing raw material costs.

Currency

The results of Praxair’s non-U.S. operations are translated to the company’s reporting currency, the U.S. dollar, from the functional currencies used in the countries in which the company operates. For most foreign operations, Praxair uses the local currency as its functional currency. There is inherent variability and unpredictability in the relationship of these functional currencies to the U.S. dollar and such currency movements may materially impact Praxair’s results of operations in any given period.

To help understand the reported results, the following is a summary of the significant currencies underlying Praxair’s consolidated results and the exchange rates used to translate the financial statements (rates of exchange expressed in units of local currency per U.S. dollar):

 

Currency

   Percent of
YTD 2007
Consolidated
Sales (a)
    Exchange rate for
Income Statement
  

Exchange rate for

Balance Sheet

     Nine-month Average    September 30,
2007
   December 31,
2006
     2007    2006      

Brazilian real

   15 %   2.00    2.18    1.84    2.14

European euro

   13 %   0.75    0.81    0.71    0.76

Canadian dollar

   8 %   1.15    1.14    1.01    1.16

Mexican peso

   5 %   10.90    10.91    10.93    10.88

Chinese RMB

   2 %   7.68    8.02    7.51    7.81

Indian rupee

   2 %   42.15    45.41    39.71    44.38

Korean won

   2 %   934    966    922    930

Argentinean peso

   1 %   3.11    3.07    3.15    3.06

Venezuelan bolivar

   1 %   2,150    2,150    2,150    2,150

(a)

Certain Surface technologies segment sales are included in European and Brazilian sales.

Climate Change

There is increasing political and scientific debate regarding the effects of human-induced greenhouse gas emissions on global climate change. Several legislative proposals are under consideration in Congress that would place limits on carbon dioxide emissions. Laws regulating greenhouse gas emissions have already been enacted in a few states, notably California and New Jersey, and bills are being considered in many other states. While it is premature to make a judgment regarding the various legislative proposals governing greenhouse gas emission controls, Praxair continues to develop new technologies designed to address anticipated long-term requirements of proposed climate change legislation.

 

20


Table of Contents

Liquidity, Capital Resources and Other Financial Data

The following selected cash flow information provides a basis for the discussion that follows:

 

(Millions of dollars)

   Nine Months Ended
September 30,
 
     2007     2006  

NET CASH PROVIDED BY (USED FOR):

    

OPERATING ACTIVITIES

    

Net income

   $ 861     $ 719  

Depreciation and amortization

     567       518  

Accounts receivable

     (222 )     (98 )

Inventory

     (55 )     (33 )

Payables and accruals

     133       109  

Pension contributions

     (16 )     (119 )

Other – net

     103       93  
                

Net cash provided by operating activities

   $ 1,371     $ 1,189  
                

INVESTING ACTIVITIES

    

Capital expenditures

   $ (974 )   $ (800 )

Acquisitions

     (349 )     (7 )

Divestitures and asset sales

     33       112  
                

Net cash used for investing activities

   $ (1,290 )   $ (695 )
                

FINANCING ACTIVITIES

    

Debt increases (reductions) – net

   $ 720     $ (346 )

Issuances of common stock

     245       203  

Purchases of common stock

     (816 )     (262 )

Cash dividends

     (287 )     (242 )

Excess tax benefit on stock option exercises

     54       18  

Minority transactions and other

     (12 )     (18 )
                

Net cash used for financing activities

   $ (96 )   $ (647 )
                

Cash Flow from Operations

Cash provided by operations of $1,371 million for the nine months ended September 30, 2007 increased $182 million versus 2006. The increase was principally a result of higher net income and lower pension contributions compared with 2006, partially offset by working capital growth related to the strong sales increase.

In the fourth quarter, cash flow from operations will reflect increased tax payments which are anticipated to be offset by the continued favorable impact of strong operating profit improvement and working capital initiatives.

Investing

Net cash used for investing of $1,290 million for the nine months ended September 30, 2007 increased $595 million versus 2006 primarily due to the acquisition of Linde AG’s industrial and medical gas business in Mexico and an independent packaged gas distributor in the United States in the first quarter of 2007 (see Note 12 to the condensed consolidated financial statements). Capital expenditures increased $174 million versus 2006 reflecting new investment in customer on-site supply systems supported by long-term customer contracts in North America, South America and Asia. In addition, 2006 included the proceeds from the divestiture of the aviation services business and a Turkish joint venture.

 

21


Table of Contents

Financing

On July 25, 2007, the company’s Board of Directors approved a $1 billion share repurchase program authorizing the company to repurchase shares from time to time on the open market or through negotiated transactions, subject to market and business conditions. Share repurchases under this program are expected to be completed within the next two years and will be financed by available cash and debt.

Cash used for financing activities of $96 million for the nine months ended September 30, 2007 decreased $551 million versus the respective 2006 period primarily due to higher debt levels used to fund acquisitions and common stock repurchases during 2007. At September 30, 2007, Praxair’s total debt outstanding was $4,003 million, an increase of $836 million from December 31, 2006. On March 15, 2007, Praxair issued $325 million of 5.20% notes due 2017 and on July 16, 2007, Praxair repaid $250 million of 4.75% Notes. Cash dividends of $287 million increased $45 million from the year ago period, reflecting a 19% increase and were $0.90 per share for the nine-month period in 2007 compared to $0.75 per share for the nine-month period in 2006.

In addition, on October 15, 2007, Praxair repaid $250 million of 6.625% Notes that were due at that time.

Legal Proceedings

See Note 9 to the condensed consolidated financial statements for a description of current legal proceedings.

Other Financial Data

Definitions of the following non-GAAP measures may not be comparable to similar definitions used by other companies. Praxair believes that its debt-to-capital ratio is appropriate for measuring its financial leverage. The company believes that its after-tax return on invested capital ratio is an appropriate measure for judging performance as it reflects the approximate after-tax profit earned as a percentage of investments by all parties in the business (debt, minority interests and shareholders’ equity). The company believes that its return on equity is an appropriate measure for judging the performance for shareholders.

 

(Dollar amounts in millions)

   September 30,
2007
    December 31,
2006
 

TOTAL CAPITAL

    

Debt

   $ 4,003     $ 3,167  

Minority interests

     255       222  

Shareholders’ equity

     4,862       4,554  
                
   $ 9,120     $ 7,943  
                

DEBT-TO-CAPITAL RATIO

     43.9 %     39.9 %

 

     Quarter Ended
September 30,
    Nine Months Ended
September 30,
 
   2007     2006     2007     2006  

AFTER-TAX RETURN ON CAPITAL (ROC)

        

Operating profit

   $ 460     $ 392     $ 1,302     $ 1,126  

Less: reported taxes

     (106 )     (101 )     (304 )     (274 )

Less: tax benefit on interest expense(a)

     (11 )     (10 )     (32 )     (31 )

Add: equity income

     4       1       13       6  
                                

Net operating profit after-tax (NOPAT)

   $ 347     $ 282     $ 979     $ 827  
                                

Beginning capital

   $ 8,784     $ 7,926     $ 7,943     $ 7,551  

Ending capital

   $ 9,120     $ 7,877     $ 9,120     $ 7,877  

Average capital

   $ 8,952     $ 7,902     $ 8,532     $ 7,714  

ROC %

     3.9 %     3.6 %     11.5 %     10.7 %

ROC % (annualized)

     15.5 %     14.3 %     15.3 %     14.3 %

(a)

Tax benefit on interest expense is based on Praxair’s underlying effective tax rates of 26% for 2007 and 26.5% for 2006.

 

22


Table of Contents
     Quarter Ended
September 30,
    Nine Months Ended
September 30,
 
   2007     2006     2007     2006  

RETURN ON EQUITY (ROE)

        

Reported net income

   $ 305     $ 247     $ 861     $ 719  

Beginning shareholders’ equity

   $ 4,850     $ 4,269     $ 4,554     $ 3,902  

Ending shareholders’ equity

   $ 4,862     $ 4,494     $ 4,862     $ 4,494  

Average shareholders’ equity

   $ 4,856     $ 4,382     $ 4,708     $ 4,198  

ROE %

     6.3 %     5.6 %     18.3 %     17.1 %

ROE % (annualized)

     25.1 %     22.5 %     24.4 %     22.8 %

Off-Balance Sheet Arrangements and Contractual Obligations

Refer to the contractual obligations and other commercial commitments table on page 40 in the Management’s Discussion and Analysis section of Praxair’s 2006 Annual Report. During the nine months ended September 30, 2007, Praxair’s outstanding letters of credit, bank guarantees and surety bonds increased to $869 million from $595 million at December 31, 2006 (see Note 9 to the condensed consolidated financial statements). Also, see Note 11 to the condensed consolidated financial statements for information related to the adoption of FIN 48, effective January 1, 2007. The adoption of FIN 48 resulted in an increase of $158 million to obligations for tax and interest liabilities related to uncertain tax positions.

New Accounting Standards

Refer to Note 1 of the condensed consolidated financial statements for information regarding new accounting standards.

Outlook

For the fourth quarter of 2007, diluted earnings per share are expected to be in the range of $0.95 to $0.97.

For the full year of 2007, Praxair expects year-over-year sales growth of about 12%. Diluted earnings per share are expected to be in the area of $3.60. Full-year capital expenditures are expected to be about $1.3 billion supporting a growing backlog of new projects and new business in all geographic regions. Praxair expects an effective tax rate of about 26% for 2007.

Praxair provides quarterly updates on operating results, material trends that may affect financial performance, and financial earnings guidance via quarterly earnings releases and investor teleconferences. These updates are available on the company’s website, www.praxair.com, but are not incorporated herein.

 

23


Table of Contents

Forward-looking Statements

This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s reasonable expectations and assumptions as of the date the statements are made but involve risks and uncertainties. These risks and uncertainties include, without limitation: the performance of stock markets generally; developments in worldwide and national economies and other international events and circumstances; changes in foreign currencies and in interest rates; the cost and availability of electric power, natural gas and other raw materials; the ability to achieve price increases to offset cost increases; catastrophic events including natural disasters, epidemics and acts of war and terrorism; the ability to attract, hire, and retain qualified personnel; the impact of changes in financial accounting standards; the impact of tax, environmental, home healthcare and other legislation and government regulation in jurisdictions in which the company operates; the cost and outcomes of investigations, litigation and regulatory proceedings, continued timely development and market acceptance of new products and applications; the impact of competitive products and pricing; future financial and operating performance of major customers and industries served; and the effectiveness and speed of integrating new acquisitions into the business. These risks and uncertainties may cause actual future results or circumstances to differ materially from the projections or estimates contained in the forward-looking statements. The company assumes no obligation to update or provide revisions to any forward-looking statement in response to changing circumstances. The above listed risks and uncertainties are further described in Item 1A (Risk Factors) in the company’s latest Annual Report on Form 10-K filed with the SEC which should be reviewed carefully. Please consider the company’s forward-looking statements in light of those risks.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Refer to the “Market Risks and Sensitivity Analyses” discussion on page 43 in the Management’s Discussion and Analysis section of Praxair’s 2006 Annual Report.

 

Item 4. Controls and Procedures

 

(a) Based on an evaluation of the effectiveness of Praxair’s disclosure controls and procedures, which was made under the supervision and with the participation of management, including Praxair’s principal executive officer and principal financial officer, the principal executive officer and principal financial officer have each concluded that, as of the end of the quarterly period covered by this report, such disclosure controls and procedures are effective in ensuring that information required to be disclosed by Praxair in reports that it files under the Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and accumulated and communicated to management including Praxair’s principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

 

(b) There were no changes in Praxair’s internal control over financial reporting that occurred during the quarterly period covered by this report that have materially affected, or are reasonably likely to materially affect, Praxair’s internal control over financial reporting.

 

Item 4T. Controls and Procedures

Not applicable.

 

24


Table of Contents

PART II – OTHER INFORMATION

Praxair, Inc. and Subsidiaries


Item 1. Legal Proceedings

See Note 9 to the condensed consolidated financial statements for a description of current legal proceedings.

 

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed in Item 1A. to Part I of Praxair’s 2006 Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities – Certain information regarding purchases made by or on behalf of the company or any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of its common stock during the quarter ended September 30, 2007 is provided below:

 

Period

   Total Number
of Shares
Purchased
  

Average
Price Paid

Per Share

   Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs(1)
   Maximum Number (or
approximate dollar
value) of Shares that
May Yet be Purchased
Under the Programs(2)
     (Thousands)         (Thousands)     

July 2007

   1,850    $ 76.63    1,850    $ 909,947

August 2007

   3,467      74.71    3,467      650,927

September 2007

   717      74.01    717      597,862
                       

Third Quarter 2007

   6,034    $ 75.22    6,034    $ 597,862
                       

(1) On July 25, 2007, the company announced that the company’s Board of Directors terminated the 1997 share repurchase program and approved a new share repurchase program pursuant to which the company may repurchase up to $1 billion of shares of its common stock from time to time at prices and on terms satisfactory to the company.

 

(2) As of September 30, 2007, the company had purchased $402 million of its common stock, pursuant to the 2007 program, leaving an additional $598 million remaining authorized for purchase under the 2007 program. The 2007 program does not have any stated expiration date.

 

Item 3. Defaults Upon Senior Securities

None.

 

25


Table of Contents
Item 4. Submission of Matters to a Vote of Security Holders

None.

 

Item 5. Other Information

None.

 

Item 6. Exhibits

 

(a) Exhibits:

 

10.20   Service Credit Arrangement for Stephen F. Angel dated May 23, 2007 was filed as exhibit 10.20 to the Company’s Form 8-K filed on May 24, 2007 and is incorporated herein by reference.
12.01   Computation of Ratio of Earnings to Fixed Charges
31.01   Rule 13a-14(a) Certification
31.02   Rule 13a-14(a) Certification
32.01   Section 1350 Certification (such certification is furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act)
32.02   Section 1350 Certification (such certification is furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act)

 

26


Table of Contents

SIGNATURE

Praxair, Inc. and Subsidiaries


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  PRAXAIR, INC.
  (Registrant)
Date: October 24, 2007   By:  

/s/ Patrick M. Clark

    Patrick M. Clark
    Vice President and Controller
    (On behalf of the Registrant
    and as Chief Accounting Officer)

 

27